WallStreetZenWallStreetZen

NASDAQ: TGTX
Tg Therapeutics Inc Stock Ownership - Who owns Tg Therapeutics?

Insider buying vs selling

Have Tg Therapeutics Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Sagar LonialDirector2024-03-135,000$15.94
$79.68kSell
Laurence N. CharneyDirector2024-03-1222,000$15.97
$351.34kSell
Laurence N. CharneyDirector2024-01-0517,500$19.03
$333.03kSell
Sean A. PowerCFO2024-01-0347,867$16.91
$809.43kSell
Michael S. WeissCEO and President2023-08-11100,000$10.13
$1.01MBuy
Sagar LonialDirector2023-06-2334,854$23.37
$814.54kSell
Sean A. PowerChief Financial Officer2023-06-0273,647$26.70
$1.97MSell

1 of 1

TGTX insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when TGTX insiders and whales buy or sell their stock.

TGTX Shareholders

What type of owners hold Tg Therapeutics Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Michael S. Weiss24.00%37,057,818$576.99MInsider
Vanguard Group Inc8.85%13,670,944$212.86MInstitution
Ra Capital Management LP8.18%12,629,868$196.65MInsider
Blackrock Inc6.97%10,768,163$167.66MInstitution
Lindsay A. Md Rosenwald6.13%9,462,616$147.33MInsider
State Street Corp5.34%8,253,573$128.51MInstitution
Biotechnologies Sasu Lfb4.93%7,614,855$118.56MInsider
Darwin Global Management Ltd2.62%4,046,598$63.01MInstitution
Joan Pons Gimbert2.56%3,959,149$61.64MInsider
Pictet Asset Management Holding Sa2.19%3,385,245$52.71MInstitution

1 of 3

TGTX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
TGTX53.78%46.22%Net SellingNet Selling
VERA55.21%44.79%Net SellingNet Selling
CLDX82.75%17.25%Net BuyingNet Buying
RXRX75.23%24.77%Net SellingNet Selling
DYN65.80%34.20%Net SellingNet Selling

Tg Therapeutics Stock Ownership FAQ

Who owns Tg Therapeutics?

Tg Therapeutics (NASDAQ: TGTX) is owned by 58.53% institutional shareholders, 50.31% Tg Therapeutics insiders, and 0.00% retail investors. Michael S. Weiss is the largest individual Tg Therapeutics shareholder, owning 37.06M shares representing 24.00% of the company. Michael S. Weiss's Tg Therapeutics shares are currently valued at $563.65M.

If you're new to stock investing, here's how to buy Tg Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.